Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

Back to all news

Congressional Briefing on Counterfeit Drugs Feb. 28, 2023

Posted 2/15/2023

This event is open to the public. Breakfast will be served from 8-830am.

Counterfeit medicines are a threat to patients, and while the U.S. drug supply is the safest in the world, it is under constant threat from criminals attempting to defraud patients and healthcare professionals.

This live briefing is the final event in a series of briefings being done for the 118th Congress. View all the briefing videos on our website:

Introduction: Tom Kubic, PSM Board Chair, Federal Bureau of Investigation (ret)

Keynote: Sen. Rick Scott (R-FL) (confirmed)

Tutorial: The Drug Supply Chain Security Act, online pharmacies, and recent counterfeits in the supply chain. (Presenter: Shabbir Imber Safdar, PSM)

Panel Talk: Foreign drug importation: U.S. and foreign stakeholders talk about the problems implementing this policy.

  • Moderator: Shabbir Imber Safdar, PSM Executive Director
  • Panelist: Joelle Walker, VP Public Affairs, Canadian Pharmacist Association
  • Panelist: Oksana Pyzik, Pharmacist & Global Health Advisor, University College London School of Pharmacy (invited)

Panel Talk: Social media, fake medicines, and drug sales: Parent advocates, law enforcement, and legislative staff talk about ways to hold illegal drug sellers on social media responsible.

  • Moderator: Shabbir Imber Safdar, PSM Executive Director
  • Panelist: Amy Neville @ Alexander Neville Foundation
  • Panelist: Natasha Butler, mother of Jerome Butler
  • Panelist: Canyon County Sheriff Kieran Donahue (invited)
  • Panelist: Additional Senate staff (invited)

Free Registration:

Back to all news

Sponsor Spotlight

IQVIA Compliance Solutions

Operational and regulatory resources for navigating the regulatory landscape with confidence

The IQVIA Difference

IQVIA has been an industry expert in DEA and state operational compliance and a leading provider of regulatory services since 1991. Our long-standing compliance solutions support the industry and the health care community in the areas of the Controlled Substance Act, Prescription Drug Marketing Act and more specifically, state pharmacy and wholesale distribution regulatory issues, as well as operational best practices.

Staffed by former DEA investigators, policy makers and industry experts, IQVIA offers comprehensive solutions to support Registrants at any stage of the journey to achieve regulatory compliance. Our expert services also include:

  • Unparalleled experience developing SOM solutions
  • State services for licensing assistance and other requirements
  • Proactively monitor the regulatory and enforcement landscapes
  • Bridge the gap between regulation and practice

All Sponsors